Literature DB >> 8013488

Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococci.

M F Tripodi1, V Attanasio, L E Adinolfi, A Florio, P Cione, S Cuccurullo, R Utili, G Ruggiero.   

Abstract

The prevalence of methicillin-resistant and multiply antibiotic-resistant staphylococci causing infections in hospitalized patients was studied over a two-year period. Among 122 clinically significant staphylococci, the prevalence of methicillin resistance was 66%, with a higher prevalence of Staphylococcus haemolyticus (85%) and Staphylococcus epidermidis (83%) observed than of Staphylococcus aureus (49%). Multiple antibiotic resistance was observed more frequently among coagulase-negative staphylococcus (52 to 70%) than among Staphylococcus aureus (17%). All strains of methicillin-resistant Staphylococcus aureus were susceptible to glycopeptide antibiotics and to trimethoprim-sulfamethoxazole, whereas approximately 50% of coagulase-negative staphylococci exhibited either moderate susceptibility or resistance to teicoplanin. For these latter strains, vancomycin remains the agent of choice, whereas teicoplanin cannot be recommended unless its efficacy is established by MIC determination.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013488     DOI: 10.1007/bf01982189

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

Review 1.  Methicillin-resistant Staphylococcus aureus.

Authors:  W Brumfitt; J Hamilton-Miller
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

2.  Emergence of vancomycin resistance in coagulase-negative staphylococci.

Authors:  R S Schwalbe; J T Stapleton; P H Gilligan
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

3.  Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.

Authors:  D E Low; A McGeer; R Poon
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

4.  Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.

Authors:  G W Kaatz; S M Seo; N J Dorman; S A Lerner
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

Review 5.  Current problems of chemotherapy of infections with coagulase-negative staphylococci.

Authors:  A J Davies; J W Stone
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

6.  Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital.

Authors:  I Shalit; S A Berger; A Gorea; H Frimerman
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

7.  Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus.

Authors:  J W Froggatt; J L Johnston; D W Galetto; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

Review 8.  Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management.

Authors:  M E Mulligan; K A Murray-Leisure; B S Ribner; H C Standiford; J F John; J A Korvick; C A Kauffman; V L Yu
Journal:  Am J Med       Date:  1993-03       Impact factor: 4.965

9.  Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species.

Authors:  F Biavasco; E Giovanetti; M P Montanari; R Lupidi; P E Varaldo
Journal:  J Antimicrob Chemother       Date:  1991-01       Impact factor: 5.790

10.  Susceptibility of Staphylococcus species and subspecies to teicoplanin.

Authors:  T L Bannerman; D L Wadiak; W E Kloos
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

View more
  5 in total

Review 1.  The treatment of staphylococcal infections with special reference to pharmacokinetic, pharmacodynamic and pharmacoeconomic considerations.

Authors:  R Janknegt
Journal:  Pharm World Sci       Date:  1997-06

2.  In-vitro activity of piperacillin/tazobactam relative to other antibiotics against blood culture isolates.

Authors:  M Cormican; G Corbett-Feeney; S Kelly; D Hughes; J Flynn; R N Jones
Journal:  Ir J Med Sci       Date:  1998 Jul-Sep       Impact factor: 1.568

3.  Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period.

Authors:  O Lyytikäinen; M Vaara; E Järviluoma; K Rosenqvist; L Tiittanen; V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

Review 4.  Vancomycin resistance in staphylococci.

Authors:  Arjun Srinivasan; James D Dick; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

5.  Frequency and antibiotic susceptibility of gram-positive bacteria in Makkah hospitals.

Authors:  Atif H Asghar
Journal:  Ann Saudi Med       Date:  2011 Sep-Oct       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.